- Home
- MYGN vs IIIN Comparison
MYGN vs IIIN Comparison
Compare MYGN & IIIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYGN
- IIIN
- Stock Information
- Founded
- MYGN 1991
- IIIN 1953
- Country
- MYGN United States
- IIIN United States
- Employees
- MYGN N/A
- IIIN N/A
- Industry
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- IIIN Steel/Iron Ore
- Sector
- MYGN Health Care
- IIIN Industrials
- Exchange
- MYGN Nasdaq
- IIIN Nasdaq
- Market Cap
- MYGN 625.5M
- IIIN 606.6M
- IPO Year
- MYGN 1995
- IIIN N/A
- Fundamental
- Price
- MYGN $6.65
- IIIN $31.53
- Analyst Decision
- MYGN Hold
- IIIN
- Analyst Count
- MYGN 14
- IIIN 0
- Target Price
- MYGN $13.23
- IIIN N/A
- AVG Volume (30 Days)
- MYGN 1.1M
- IIIN 136.7K
- Earning Date
- MYGN 11-03-2025
- IIIN 10-16-2025
- Dividend Yield
- MYGN N/A
- IIIN 3.51%
- EPS Growth
- MYGN N/A
- IIIN 112.14
- EPS
- MYGN N/A
- IIIN 2.10
- Revenue
- MYGN $825,300,000.00
- IIIN $647,706,000.00
- Revenue This Year
- MYGN $0.06
- IIIN $14.97
- Revenue Next Year
- MYGN $5.68
- IIIN $7.00
- P/E Ratio
- MYGN N/A
- IIIN $15.20
- Revenue Growth
- MYGN 0.21
- IIIN 22.39
- 52 Week Low
- MYGN $3.76
- IIIN $22.49
- 52 Week High
- MYGN $16.83
- IIIN $41.64
- Technical
- Relative Strength Index (RSI)
- MYGN 41.25
- IIIN 36.74
- Support Level
- MYGN $6.25
- IIIN $31.00
- Resistance Level
- MYGN $6.83
- IIIN $32.87
- Average True Range (ATR)
- MYGN 0.43
- IIIN 0.82
- MACD
- MYGN -0.09
- IIIN 0.28
- Stochastic Oscillator
- MYGN 23.90
- IIIN 36.40
About MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.
About IIIN Insteel Industries Inc.
Insteel Industries Inc produces and sells prestressed concrete strand (PC strand) and welded wire reinforcement (WWR). PC strand, a high-strength seven-wire cable, is used to strengthen precast concrete in structures like bridges, parking decks, and buildings, enabling longer spans and slimmer designs. WWR includes engineered structural mesh for primary reinforcement, concrete pipe reinforcement for drainage and sewage systems, and standard WWR for crack control in residential and light commercial construction. The company serves markets in the United States and internationally, with the majority of revenue generated in the United States.